Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

TAURINE AND PAINFUL DIABETIC NEUROPATHY

Award Number: R01AT002146
ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/29/2004
PERIOD OF PERFORMANCE END DATE: 06/30/2009

Group Awards By:

View Award Description

TAURINE AND PAINFUL DIABETIC NEUROPATHY - DESCRIPTION (provided by applicant): Taurine and Painful Diabetic Neuropathy Diabetic neuropathy (DN) commonly complicates diabetes and can lead to lower limb amputations. In diabetes, neuropathic pain reduces quality of life, contributes to depression, limits exercise and impairs metabolic control thereby contributing to excess cardiovascular risk. Currently there are no treatments for DN other than improved metabolic control and conventional treatment for painful neuropathy can be cardiotoxic and have low efficacy. The etiology of pain complicating diabetes is poorly understood but may result from dysfunction of pain signaling pathways at multiple levels including cutaneous nociceptors, afferent neurons and spinal and supraspinal pathways. Taurine is a ubiquitous a amino acid, which functions as an antioxidant, regulator of glucose sensitive signal transduction pathways and analgesic such that its depletion in diabetes may contribute to the development of DN and pain. We have identified taurine depletion in the peripheral nerve of diabetic rodents and shown that taurine repletion alleviates hyperalgesia and prevents nerve metabolic, vascular and functional deficits. This proposal extends these observations and aims to explore the ability of taurine treatment alone to decrease pain and in combination with D-L-a-lipoic acid to improve nerve structure and function in patients with DN. The overall hypothesis is that taurine depletion contributes to the development of painful DN. The rationale is based on: (a) evidence implicating oxidative stress, altered neuronal calcium signaling and neuronal hyperexcitability in the development of painful DN (b) the emerging role of taurine as an important endogenous antioxidant, calcium regulator, neurotrophin, modulator of neuronal hyperexcitability and analgesic and (c) our data implicating an important role for taurine depletion and oxidative stress in the pathogenesis of experimental DN. The experimental approach will be to utilize biochemical, electrophysiological and imaging techniques to test the following aims: 1. Determine whether neuropathic pain complicating diabetes can be ameliorated by therapy with taurine. 2. Determine whether nerve functional and structural deficits complicating diabetes can be ameliorated by combination therapy with taurine and D-L-a-Iipoic acid. These studies will test a novel mechanistically based therapeutic approach to a common disabling and often-refractory complication of diabetes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2009 ( Subtotal = $0 )
2009	2007	UNIVERSITY OF BIRMINGHAM	EDGBASTON	BIRMINGHAM				GBR	Research and Training in Complementary and Integrative Health	000	4	11/14/2008	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2007 ( Subtotal = $326,542 )
2007	2007	UNIVERSITY OF BIRMINGHAM	EDGBASTON	BIRMINGHAM				GBR	Research and Training in Complementary and Integrative Health	000	4	8/20/2007	NON-COMPETING CONTINUATION	$326,542
														Subtotal = $326,542

Issue Date FY: 2006 ( Subtotal = $326,542 )
2006	2006	UNIVERSITY OF BIRMINGHAM	EDGBASTON	BIRMINGHAM				GBR	Research and Training in Complementary and Integrative Health	000	3	8/9/2006	NON-COMPETING CONTINUATION	$326,542
														Subtotal = $326,542

Issue Date FY: 2005 ( Subtotal = $335,683 )
2005	2005	UNIVERSITY OF BIRMINGHAM	EDGBASTON	BIRMINGHAM				GBR	Research and Training in Complementary and Integrative Health	000	2	9/16/2005	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$335,683
														Subtotal = $335,683

Issue Date FY: 2004 ( Subtotal = $336,600 )
2004	2004	UNIVERSITY OF MICHIGAN	3003 S STATE ST 3089 WOLVERINE	ANN ARBOR	MI	48109	WASHTENAW	USA	Research and Training in Complementary and Integrative Health	000	1	9/24/2004	NEW	$336,600
														Subtotal = $336,600

Grand Total All Awards = $1,325,367

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TAURINE AND PAINFUL DIABETIC NEUROPATHY

Award Number: R01AT002146

ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/29/2004

PERIOD OF PERFORMANCE END DATE: 06/30/2009

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer